Arecor Therapeutics
Arecor is a revenue-generating clinical-stage drug developer. Its proprietary Arestat formulation platforms are the basis of an in-house and partnered pipeline of enhanced products with lower development risks and less onerous regulatory approvals.
View MoreSpecialty Hospital products formulation collaboration
Arecor Therapeutics | Lighthouse | 10 November 2022
View MoreAT247 Phase I pump data confirms promising profile
Arecor Therapeutics | Lighthouse | 11 October 2022
View MoreBroadening opportunities and preparing for the future
Arecor Therapeutics | Update | 21 September 2022
View MoreKey clinical diabetes events on track for H222
Arecor Therapeutics | Lighthouse | 8 September 2022
View MoreAcquisition of Tetris Pharma and £6m equity raise
Arecor Therapeutics | Lighthouse | 01 August 2022
View MoreAmbitious, focussed, and delivering on its promise
Arecor Therapeutics | Update | 25 April 2022
View MoreFormulation expertise exemplified in diabetes
Arecor Therapeutics | Update | 20 January 2021
View MoreH121 results underline quality of management execution
Arecor Therapeutics | Lighthouse | 23 September 2021
View More
1
2